Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
Read the full story at Bloomberg AI ↗
Timeline · 2 reports
- 2026-10-08 06:25 · Bloomberg AI
Isomorphic Labs Seeks Funding at Valuation of $40 Billion - 2026-10-08 04:00 · Bloomberg AI
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value